Publication | Open Access
Inhibition of H1N1 influenza virus by selenium nanoparticles loaded with zanamivir through p38 and JNK signaling pathways
69
Citations
40
References
2017
Year
ImmunologyPharmacotherapyFlu VaccinationAntiviral DrugNanomedicineAntiviral Drug DevelopmentH1n1 Influenza VirusVirologyPharmacologyAntiviral CompoundStrong Molecular PolarityAntiviral TherapyInfluenza VaccineSelenium NanoparticlesInfluenza Virus InfectionMedicineEffective DrugJnk Signaling PathwaysDrug Discovery
Zanamivir is an effective drug for influenza virus infection, but strong molecular polarity and aqueous solubility limit its clinical application.
| Year | Citations | |
|---|---|---|
2012 | 1.4K | |
2016 | 1K | |
2014 | 435 | |
2013 | 371 | |
2015 | 261 | |
2013 | 202 | |
2016 | 175 | |
2015 | 136 | |
2016 | 115 | |
2017 | 102 |
Page 1
Page 1